Perspective Therapeutics Inc
Perspective Therapeutics Inc (CATX) Implied Volatility Current
CATX implied volatility is 137%. IV Rank is 25%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking CATX implied volatility helps you identify when options premiums on Perspective Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Perspective Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when CATX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Perspective Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CATX, tracking metrics like CATX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CATX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc.
in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CATX implied volatility sits today versus where it has been. Our scanner ranks Perspective Therapeutics Inc implied volatility against its historical range, surfaces extremes in CATX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Perspective Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 18, 2026
Trade options with IV on your side
Track CATX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→